# MicroActive Curcumin (Curcuma longa) **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/microactive-curcumin **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-19 **Evidence Score:** 2 / 10 **Category:** Other **Also Known As:** Curcuma longa, turmeric, Indian saffron, golden spice, haldi, jiang huang, ukon, haridra ## Overview MicroActive Curcumin is a bioavailability-enhanced form of curcumin from Curcuma longa root that uses proprietary microencapsulation technology. The formulation aims to improve absorption of curcumin, which modulates [inflammatory pathway](/ingredients/condition/inflammation)s including NF-κB and cyclooxygenase enzymes. ## Health Benefits • No specific clinical benefits documented for MicroActive Curcumin in available research (evidence quality: none) • [Antioxidant](/ingredients/condition/antioxidant) properties demonstrated in extraction studies showing higher TPC and ABTS values (evidence quality: preliminary/in-vitro only) • General curcumin research exists for inflammation and osteoarthritis (PMID: 30681719) but not linked to this branded form (evidence quality: not applicable) • Traditional use suggests digestive and [anti-inflammatory](/ingredients/condition/inflammation) support spanning 4,000 years (evidence quality: traditional only) • No human clinical trials found for MicroActive Curcumin specifically (evidence quality: insufficient) ## Mechanism of Action MicroActive Curcumin delivers curcumin compounds that inhibit nuclear factor-kappa B (NF-κB) transcription, reducing [inflammatory](/ingredients/condition/inflammation) cytokine production. The active curcuminoids also suppress cyclooxygenase-2 (COX-2) and lipoxygenase enzymes while scavenging [reactive oxygen species](/ingredients/condition/antioxidant). The microencapsulation technology enhances bioavailability compared to standard curcumin extracts. ## Clinical Summary No specific clinical trials have been published examining MicroActive Curcumin's therapeutic effects in humans. Preliminary extraction studies demonstrate higher total phenolic content and ABTS [antioxidant activity](/ingredients/condition/antioxidant) compared to conventional extracts. General curcumin research shows [anti-inflammatory](/ingredients/condition/inflammation) effects in various studies, but specific evidence for this enhanced formulation remains limited. More clinical research is needed to validate therapeutic claims for MicroActive Curcumin specifically. ## Nutritional Profile MicroActive Curcumin is a patented sustained-release formulation of curcumin derived from Curcuma longa (turmeric) rhizome. Primary bioactive compounds: curcuminoids complex comprising curcumin (diferuloylmethane, typically ~75-80% of curcuminoid content), demethoxycurcumin (~15-20%), and bisdemethoxycurcumin (~3-5%). Standard doses deliver approximately 200-600 mg curcuminoids per serving depending on product formulation. Negligible macronutrient contribution (minimal calories, protein, fat, carbohydrates per dose). No significant vitamins or minerals at supplemental doses. Key bioactive compounds include polyphenolic curcuminoids which function as [antioxidant](/ingredients/condition/antioxidant)s (demonstrated via elevated Total Phenolic Content/TPC and ABTS radical scavenging assays in extraction studies). The MicroActive delivery system utilizes a sustained-release matrix (typically involving a combination of curcumin with a colloidal dispersion or micronized polymer coating) designed to provide extended release over ~12 hours. Bioavailability notes: Native curcumin has notoriously poor oral bioavailability (<1% in some studies) due to rapid Phase II [metabolism](/ingredients/condition/weight-management) (glucuronidation and sulfation), poor aqueous solubility (~11 ng/mL at pH 5.0), and rapid systemic elimination. The MicroActive formulation claims enhanced and sustained plasma curcumin levels compared to standard curcumin extract, though independent peer-reviewed pharmacokinetic comparisons specifically validating this branded form's bioavailability advantage (e.g., AUC, Cmax data versus unformulated curcumin or competing formulations like Meriva, Longvida, BCM-95, or CurcuWin) are not well-documented in publicly available clinical literature. Contains no significant fiber or protein. Typical excipients may include starch, cellulose derivatives, or other sustained-release matrix components depending on manufacturer specifications. Fat-soluble compound; co-administration with dietary lipids may further support absorption of any immediate-release fraction. ## Dosage & Preparation No clinically studied dosage ranges are available for MicroActive Curcumin. The research only indicates standardization targets of 2-9% curcuminoids in generic turmeric oleoresins, with extraction yields up to 4.98% via microwave-assisted extraction, but these do not translate to human dosing recommendations. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions MicroActive Curcumin likely shares the safety profile of standard curcumin, which is generally well-tolerated at typical doses. Curcumin may increase bleeding risk when combined with anticoagulant medications like warfarin or antiplatelet drugs. High doses may cause gastrointestinal upset, nausea, or diarrhea in sensitive individuals. Pregnant and breastfeeding women should avoid supplemental doses due to insufficient safety data. ## Scientific Research No human clinical trials, RCTs, or meta-analyses were found specifically for MicroActive Curcumin in the available research. While general curcumin research exists elsewhere (such as PMID: 30681719 for osteoarthritis meta-analysis), none of these studies link to or evaluate the MicroActive branded formulation. ## Historical & Cultural Context Turmeric (Curcuma longa) has been used in Ayurvedic and traditional Indian medicine for over 4,000 years for [inflammation](/ingredients/condition/inflammation), [digestion](/ingredients/condition/gut-health), and wound healing. However, the available research focuses on modern extraction methods rather than traditional preparation or usage details. ## Synergistic Combinations Black pepper extract (piperine), ginger extract, boswellia, quercetin, omega-3 fatty acids ## Frequently Asked Questions ### What makes MicroActive Curcumin different from regular curcumin? MicroActive Curcumin uses proprietary microencapsulation technology to enhance bioavailability compared to standard curcumin extracts. This formulation aims to improve absorption of curcuminoids, though specific clinical data on this enhanced form remains limited. ### What is the recommended dosage for MicroActive Curcumin? Specific dosage recommendations for MicroActive Curcumin vary by manufacturer, typically ranging from 200-500mg daily. Since no clinical trials have established optimal dosing for this specific formulation, consult healthcare providers for personalized recommendations. ### Can MicroActive Curcumin be taken with other supplements? MicroActive Curcumin can generally be combined with most supplements, but may enhance the effects of blood-thinning compounds. Avoid combining with high-dose anticoagulant herbs like ginkgo or garlic without medical supervision due to potential additive bleeding risks. ### How long does it take for MicroActive Curcumin to work? While the enhanced bioavailability may improve absorption speed, no studies have specifically measured onset time for MicroActive Curcumin. General curcumin research suggests anti-inflammatory effects may begin within hours, but sustained benefits typically require weeks of consistent use. ### Is MicroActive Curcumin better absorbed than turmeric powder? Yes, MicroActive Curcumin is designed to be significantly better absorbed than whole turmeric powder, which contains only 2-5% curcumin with poor bioavailability. The microencapsulation technology specifically addresses curcumin's natural absorption limitations in the digestive system. ### Is MicroActive Curcumin safe to take during pregnancy or while breastfeeding? While curcumin from turmeric is generally considered safe in food amounts, high-dose supplementation during pregnancy and breastfeeding has not been adequately studied, and MicroActive Curcumin's concentrated form makes this a particular concern. Pregnant and breastfeeding women should consult their healthcare provider before taking this supplement, as curcumin may cross the placental barrier and pass into breast milk. ### Does MicroActive Curcumin interact with blood thinners or anticoagulant medications? Curcumin may have mild anticoagulant properties and could theoretically interact with blood thinners like warfarin or aspirin, though significant interactions are not well-documented in clinical studies. If you are taking anticoagulant medications, inform your healthcare provider before starting MicroActive Curcumin to ensure safe concurrent use. ### What does research actually show about MicroActive Curcumin's effectiveness? While extraction studies demonstrate that MicroActive Curcumin has higher antioxidant values in laboratory settings compared to standard curcumin, there are no published clinical trials specifically testing this branded form in humans. General curcumin research supports potential benefits for inflammation and joint health, but these findings cannot be automatically attributed to this proprietary formulation without dedicated human studies. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*